ABIRATERONE ACETATE vs SOGROYA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. ABIRATERONE ACETATE and SOGROYA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ABIRATERONE ACETATE	SOGROYA
Rating	72/100	70/100
Pharmacy pays	~$25.50 /30	—
Type	RX	RX
Active ingredient	ABIRATERONE ACETATE	SOMAPACITAN-BECO
Manufacturer	Hikma	Novo Nordisk Inc
Dosage forms	Tablet	Injectable
Drug class	Cytochrome P450 17a1 Inhibitor	—
Boxed warning	None	None
Treats	Castration-Resistant Prostatic Neoplasms	—

abiraterone acetate sogroya

Rating

72/100

70/100

Pharmacy pays

~$25.50 /30

—

Type

Active ingredient

ABIRATERONE ACETATE

SOMAPACITAN-BECO

Manufacturer

Hikma

Novo Nordisk Inc

Dosage forms

Tablet

Injectable

Drug class

Cytochrome P450 17a1 Inhibitor

—

Boxed warning

None

Treats

Castration-Resistant Prostatic Neoplasms

—

Frequently asked questions

Which is better-rated, Abiraterone Acetate or Sogroya?

By our independent rating, Abiraterone Acetate scores higher — 3.6 vs 3.5 out of 5 for Sogroya. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Abiraterone Acetate and Sogroya?

Abiraterone Acetate contains Abiraterone Acetate, while Sogroya contains Somapacitan-Beco — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.